Prognostic value of chemotherapy response score in advanced ovarian cancer: a single-center retrospective analysis

ABSTRACT BACKGROUND: The chemotherapy response score (CRS) is a histopathological tool used to assess the tumor response in patients with high-grade serous ovarian carcinoma (HGSC) undergoing neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS). DESIGN AND SETTING: This sin...

Full description

Bibliographic Details

Published in:	São Paulo Medical Journal
Main Authors:	Hamdullah Sözen, Yagmur Minareci, Atahan Toyran, Ibrahim Yalçin, Semen Önder, Aysel Bayram, Sidar Bağbudar, Mustafa Albayrak, Müge Ateş Tikiz, Pınar Mualla Saip, Samet Topuz, Mehmet Yavuz Salihoglu
Format:	Article
Language:	English
Published:	Associação Paulista de Medicina 2025-10-01
Subjects:	Ovarian neoplasms Neoadjuvant therapy Survival analysis Interval debulking surgery Chemotherapy response score High-grade serous ovarian carcinoma Overall survival Disease-free survival
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802025000600208&lng=en&tlng=en